News Detail
Maryland, 26 July 2024: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and lax controls to prevent mic......
View Details
Source : Regulatory Focus
US Food and Drug Administration (FDA)
good manufacturing practice (GMP) violations
falsifying sterility and environmental monitoring data
Related News
- ICMR releases 32 new treatment standards for treating common and serious diseases (26-07-2024)
- Indian national charged with selling counterfeit cancer drugs (26-07-2024)
- DCA Raids Shops Selling Habit-Forming Drugs (25-07-2024)
- BIS Sanctioned 82 Medical Device projects to develop standards (25-07-2024)
- Anti-Narcotics Task Force will be formed soon in Rajasthan: HM (25-07-2024)
- ICMR to strengthen IPR unit to safeguard and commercialize scientific innovations (25-07-2024)
- Health Budget focuses on strengthening state drug regulatory systems (25-07-2024)
- Ignorance of law no excuse, says HC; refuses to quash case against pharma firm Director (25-07-2024)
- DCA Telangana busted in Joint Raid, Godown stocking 23 type of illegally manufactured bulk drugs, APIs worth Rs. 96 lakhs seized (24-07-2024)
- Will operationalise Anusandhan National Research Foundation (ANRF): Sitharaman (24-07-2024)